Blaze Bioscience, Inc. is a privately held biotechnology company dedicated to improving the lives of cancer patients, starting with kids undergoing brain cancer surgery. By leveraging our Tumor Paint technology®, including the CANVAS Imaging system® and our CDP Discovery Platform, our goal is to make the detection, removal, and treatment of all cancers sensitive, reliable, and accessible, especially early-stage cancers where cure may still be possible.
Looking for a particular Blaze Bioscience employee's phone or email?
The Blaze Bioscience annual revenue was $13.6 million in 2026.
Steven Daly is the President and CEO of Blaze Bioscience.
6 people are employed at Blaze Bioscience.
Blaze Bioscience is based in Seattle, Washington.
The NAICS codes for Blaze Bioscience are [5417, 541714, 541, 54171, 54].
The SIC codes for Blaze Bioscience are [873, 87].